A Phase 3 Trial of OPA-15406 Foam in Children and Infants With Atopic Dermatitis

NCT07184645 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

198

Enrollment

INDUSTRY

Sponsor class

Conditions

Atopic Dermatitis (AD)

Interventions

DRUG: OPA-15406
DRUG: Vehicle

Sponsor

Otsuka Pharmaceutical Co., Ltd.